Stephen Elms is an experienced CEO focused on transitioning university technologies to the market place. He was CEO and founder of Miomics Bio-Therapeutics, a company working to commercialize a therapeutic drug first developed in the Mayo Clinic. He is very effective in networking and structuring partnerships, and developing high value companies. He has prior experience in international finance and trading.